Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LAPTM4B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MPPED1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PIGX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PLA2G15 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CDK18 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MCEMP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TAP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SLA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CEBPB | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CNPY4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |